Phenylalanine free infant formula in the dietary management of phenylketonuria.
Acceptability
Formula
Growth
Infancy
Infant protein substitute
Phenylketonuria
Journal
Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602
Informations de publication
Date de publication:
25 01 2023
25 01 2023
Historique:
received:
07
11
2022
accepted:
15
01
2023
entrez:
26
1
2023
pubmed:
27
1
2023
medline:
28
1
2023
Statut:
epublish
Résumé
Phenylalanine-free infant formula is an essential source of safe protein in a phenylalanine restricted diet, but its efficacy is rarely studied. We report a multicentre, open, longitudinal, prospective intervention study on a phenylalanine-free infant formula (PKU Start: Vitaflo International Ltd.). This was a 2-part study: part I (28 days short term evaluation) and part II (12 months extension). Data was collected on infant blood phenylalanine concentrations, dietary intake, growth, and gastrointestinal tolerance. Ten infants (n = 8 males, 80%), with a median age of 14 weeks (range 4-36 weeks) were recruited from 3 treatment centres in the UK. Nine of ten infants completed the 28-day follow-up (one caregiver preferred the usual phenylalanine-free formula and discontinued the study formula after day 14) and 7/9 participated in study part II. The phenylalanine-free infant formula contributed a median of 57% (IQR 50-62%) energy and 53% (IQR 33-66%) of total protein intake from baseline to the end of the part II extension study. During the 12-month follow-up, infants maintained normal growth and satisfactory blood phenylalanine control. Any early gastrointestinal symptoms (constipation, colic, vomiting and poor feeding) improved with time. The study formula was well tolerated, helped maintain good metabolic control, and normal growth in infants with PKU. The long-term efficacy of phenylalanine-free infant formula should continue to be observed and monitored.
Sections du résumé
BACKGROUND
Phenylalanine-free infant formula is an essential source of safe protein in a phenylalanine restricted diet, but its efficacy is rarely studied. We report a multicentre, open, longitudinal, prospective intervention study on a phenylalanine-free infant formula (PKU Start: Vitaflo International Ltd.).
RESULTS
This was a 2-part study: part I (28 days short term evaluation) and part II (12 months extension). Data was collected on infant blood phenylalanine concentrations, dietary intake, growth, and gastrointestinal tolerance. Ten infants (n = 8 males, 80%), with a median age of 14 weeks (range 4-36 weeks) were recruited from 3 treatment centres in the UK. Nine of ten infants completed the 28-day follow-up (one caregiver preferred the usual phenylalanine-free formula and discontinued the study formula after day 14) and 7/9 participated in study part II. The phenylalanine-free infant formula contributed a median of 57% (IQR 50-62%) energy and 53% (IQR 33-66%) of total protein intake from baseline to the end of the part II extension study. During the 12-month follow-up, infants maintained normal growth and satisfactory blood phenylalanine control. Any early gastrointestinal symptoms (constipation, colic, vomiting and poor feeding) improved with time.
CONCLUSION
The study formula was well tolerated, helped maintain good metabolic control, and normal growth in infants with PKU. The long-term efficacy of phenylalanine-free infant formula should continue to be observed and monitored.
Identifiants
pubmed: 36698214
doi: 10.1186/s13023-023-02621-9
pii: 10.1186/s13023-023-02621-9
pmc: PMC9878783
doi:
Substances chimiques
Phenylalanine
47E5O17Y3R
Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
16Informations de copyright
© 2023. The Author(s).
Références
J Pediatr. 2021 Dec;239:231-234.e2
pubmed: 34474089
Acta Paediatr Suppl. 1994 Dec;407:66-7
pubmed: 7766962
Mol Genet Metab. 2011;104 Suppl:S55-9
pubmed: 21967856
Arch Dis Child. 1970 Oct;45(243):640-50
pubmed: 5477678
J Inherit Metab Dis. 2003;26(1):1-11
pubmed: 12872834
Nutrients. 2021 Feb 02;13(2):
pubmed: 33540516
Orphanet J Rare Dis. 2020 Jun 30;15(1):171
pubmed: 32605583
Am J Hum Genet. 2020 Aug 6;107(2):234-250
pubmed: 32668217
Dev Med Child Neurol. 2006 Mar;48(3):207-12
pubmed: 16483397
J Hum Nutr Diet. 2018 Jun;31(3):349-356
pubmed: 28940742
Nutrients. 2019 Mar 05;11(3):
pubmed: 30841589
Mol Genet Metab. 2011;104 Suppl:S10-8
pubmed: 21944460
J Inherit Metab Dis. 2010 Dec;33(6):671-6
pubmed: 20976625
Br Med J. 1955 Jan 8;1(4905):57-64
pubmed: 13219342
Arch Dis Child. 1975 Nov;50(11):864-70
pubmed: 1211959
J Inherit Metab Dis. 2005;28(6):845-54
pubmed: 16435176
Acta Paediatr Suppl. 1999 Dec;88(432):25-7
pubmed: 10626572
Acta Paediatr Suppl. 2006 Apr;450:76-85
pubmed: 16817681
Nutr Res Rev. 2019 Jun;32(1):70-78
pubmed: 30284526
Am J Clin Nutr. 2016 Feb;103(2):303-4
pubmed: 26791192
J Am Coll Nutr. 1993 Apr;12(2):108-14
pubmed: 8463509
Dig Liver Dis. 2005 Jun;37(6):432-8
pubmed: 15893282
Arch Dis Child Fetal Neonatal Ed. 2019 May;104(3):F333-F340
pubmed: 30523072
Nutrients. 2018 Nov 18;10(11):
pubmed: 30453665
J Pediatr Gastroenterol Nutr. 1998 Sep;27(3):287-91
pubmed: 9740198
J Pediatr Nurs. 2012 Aug;27(4):319-27
pubmed: 22703678
J Am Coll Nutr. 1999 Apr;18(2):102-7
pubmed: 10204824
Clin Nutr. 2009 Jun;28(3):231-6
pubmed: 19362397
J Hum Nutr Diet. 2012 Apr;25(2):103-10
pubmed: 21819461
Pediatrics. 2013 Dec;132(6):987-9
pubmed: 24276841
Adv Nutr. 2011 May;2(3):275-83
pubmed: 22332059
Eur J Pediatr. 1994 Jul;153(7):537-8
pubmed: 7957375
Eur J Nutr. 2022 Jun;61(4):2167-2182
pubmed: 35072787
J Pediatr Gastroenterol Nutr. 2005 Nov;41(5):584-99
pubmed: 16254515
Sci Rep. 2018 Jun 21;8(1):9433
pubmed: 29930401
Eur J Clin Nutr. 2016 Jul;70(7):785-9
pubmed: 27117930
Clin Exp Pediatr. 2020 Aug;63(8):301-309
pubmed: 32252145
Food Funct. 2019 Apr 17;10(4):2102-2113
pubmed: 30919834
Nutrients. 2019 Nov 12;11(11):
pubmed: 31718111
J Dairy Sci. 2010 Jul;93(7):2857-62
pubmed: 20630202
J Hum Nutr Diet. 2013 Feb;26(1):32-7
pubmed: 23210913
J Inherit Metab Dis. 2010 Dec;33(6):659-64
pubmed: 20151202
Lancet. 1953 Oct 17;265(6790):812-3
pubmed: 13098090
Nutrients. 2016 May 11;8(5):
pubmed: 27187450
Orphanet J Rare Dis. 2017 Oct 12;12(1):162
pubmed: 29025426
Rep Health Soc Subj (Lond). 1977;12:i-xi, 1-47
pubmed: 860083
Nutr Metab (Lond). 2012 Feb 03;9(1):7
pubmed: 22305125
J Clin Invest. 1999 Apr;103(8):1169-78
pubmed: 10207169
Am J Clin Nutr. 2011 Dec;94(6 Suppl):1776S-1784S
pubmed: 21849603
Lancet. 2010 Oct 23;376(9750):1417-27
pubmed: 20971365
Acta Paediatr. 1994 May;83(5):534-41
pubmed: 8086734
World Health Organ Tech Rep Ser. 2007;(935):1-265, back cover
pubmed: 18330140
Pediatrics. 1976 Feb;57(2):278-85
pubmed: 1250665
Front Pediatr. 2020 Jan 24;7:563
pubmed: 32039120
Semin Perinatol. 2021 Mar;45(2):151380
pubmed: 33431112